ModernMedicine Resource Center More Topics


Law Reauthorizes FDA Fees and Increases Access to Generics/BiosimilarsSenate passes FDARA overwhelmingly, ahead of September deadline.
Gottlieb Pushes for Generic Drug AccessBrand name drug companies are "gaming" the system, according to the FDA head.
Brace for a barrage of biosimilarsThe next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.
Generic Cholesterol Meds a Boon for PatientsTwo recent generic cholesterol-lowering drugs are helping reduce health-care costs.
Priority Generic Drugs to Get Faster FDA ReviewFDA will shorten the review periods for priority generic drugs by two months.
Supreme Court Ruling Raises Biosimilars’ AccessHigh court ruling should make biosimilars available faster.
AAM Report on Generics Finds High Brand Abandonment RatePatients are less like to buy a requested brand name prescription than a generic one.
Inexpensive Generic Prevents Bleeding Deaths after ChildbirthGeneric drug prevents post-birth bleeding deaths
Study: Generic Prescribing Increased When Sales Rep Influence Was LimitedStudy shows that anti-detailing policies can increase generic prescribing.
CVS: Generics and Biosimilars Are Key to Its Drug Spending DeclineDrug spending is going down at CVS Caremark. Here’s why.